Showing posts with label promise in treating pancreatic cancer patients with BRCA mutation. Show all posts
Showing posts with label promise in treating pancreatic cancer patients with BRCA mutation. Show all posts
Wednesday, December 21, 2016

Targeted therapy rucaparib shows promise in treating pancreatic cancer patients with BRCA mutation

›
The targeted therapy rucaparib, which has demonstrated robust clinical activity in ovarian cancer patients with a BRCA mutation, also show...